References
- Blombäck B., Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi 1956; 10: 415
- Brakman P. Bovine fibrinogen without de tectable plasminogen. Analyt. Biochem. 1965; 11: 149
- Ekelund H., Hedner U., Nilsson I. M. Fibrinolysis in newborns. Acta paediat. scand. 1970; 59: 33
- Eriksson S. Studies in α1-antitrypsin deficiency. Acta med. scand. Suppl. 1965; 432
- Ganrot P. O. Determination of α2-macro globulin as trypsin-protein esterase. Clin. chim. Acta 1966; 14: 493
- Ganrot P. O., Niléhn J. E. Immunochemical determination of human plasminogen. Clin. chim. Acta 1968; 22: 335
- Hedner U., Nilsson I. M. Determination of plasminogen in human plasma by a casein method. Thrombos. Diathes. haemorrh. (Stuttg.) 1955; 14: 545
- Jacobsen C. D. A family with low proteolytic capacity in plasma, probably related to a low plasminogen content. Scand. J. clin. Lab. Invest. 1966; 18: 359
- Jacobsen C. D. Proteolytic capacity in human plasma. Part I. Measurement of proteolytic activity in tne presence or natural inhibitors and study of the inter-individual variations. Scand. J. clin. Lab. Invest. 1968; 21: 216
- Jacobsen C. D. Proteolytic capacity in human plasma. Part II. Genetics, and clinical study. Scand. J. clin. Lab. Invest. 1968; 21: 227
- Lauritsen O. S. Urokinase inhibitor in human plasma. Scand. J. clin. Lab. Invest. 1968; 22: 314
- Lauritsen O. S. Activation of porcine plas minogen by human urokinase. Scand. J. clin. Lab. Invest. 1968; 22: 239
- Müllertz S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem. J. 1955; 61: 424
- Niléhn J. E., Ganrot P. O. Plasmin, plasmin inhibitors and degradation products of fibrino gen in human serum during and after intraven ous infusion of streptokinase. Scand. J. clin. Lab. Invest. 1967; 20: 113
- Nilsson I. M., Skanse B., Gydell K. Fibrin olysis in Boeck's sarcoid. Acta med. scand. 1957; 159: 463
- Nilsson I. M., Krook H., Sternby N.-H., Söderberg E., Söderström N. Severe throm botic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta med. scand. 1961; 169: 323
- Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest. 1962; 14: 138
- Shamash Y., Rimon A. The plasmin inhib itors of plasma. I. A method for their estima tion. Thrombos. Diathes. haemorrh. (Stuttg.) 1964; 12: 119